Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower Versus Higher Dialysate Bicarbonate in Hospitalized Maintenance Hemodialysis Patients
NCT05814146Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bicarbonate dialysate in end stage renal disease (ESRD) (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: QTc prolongation. Started Aug 2023; status: recruiting.
02
Drugs
bicarbonate dialysate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05814146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814146.